Sandrine Crommer

CD19-/CD3-bispecific antibody of the BiTE class is far superior to tandem diabody with respect to redirected tumor cell lysis.

P. Hoffmann, P. Kufer, M. Mølhøj, 2007, Molecular immunology.

Serial killing of tumor cells by cytotoxic T cells redirected with a CD19‐/CD3‐bispecific single‐chain antibody construct

P. Hoffmann, P. Baeuerle, C. Itin, 2005, International journal of cancer.

Exchanging human Fcγ1 with murine Fcγ2a highly potentiates anti-tumor activity of anti-EpCAM antibody adecatumumab in a syngeneic mouse lung metastasis model

P. Baeuerle, R. Hofmeister, B. Schlereth, 2007, Cancer Immunology, Immunotherapy.